Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor

    loading  Checking for direct PDF access through Ovid


We report here on an elderly patient, aged 88 years, who developed acquired hemophilia, with a high titer of factor VIII inhibitors and severe hemorrhage, in the absence of a detectable cause. Marked and prolonged efficacy was observed after rituximab.

Related Topics

    loading  Loading Related Articles